CA58504D1006
© Globe Newswire
11.12.2025
LABS
LISTED
TSX
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
News Preview
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.12.2025
LABS
LISTED
TSX
MediPharm Labs Completes First Shipment to France
News Preview
MediPharm Labs is pleased to announce the completion of the Company's first shipment to France....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
LABS
LISTED
TSX
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
News Preview
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the “Court”) has fully dismissed the statement of claim (CV-25-0...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
13.11.2025
LABS
LISTED
TSX
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
News Preview
MediPharm delivered another successful quarter of strong year-over-year revenue growth in the three months ended September 30, 2025 ("Q3 2025")....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.11.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
News Preview
MediPharm will release its third quarter financial results before markets open on Thursday, November 13th, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
LABS
LISTED
TSX
/U P D A T E -- MediPharm Labs Corp./
News Preview
In the news release, MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees, issued 15-May-2025 by MediPharm Labs Corp. over PR Newswire, please be advised that updates have been made throughout the release and will replace the prior version in full:
MediPharm Labs Raises Concerns About Poorly Qua...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
LABS
LISTED
TSX
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
News Preview
TORONTO, May 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Spe...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
LABS
LISTED
TSX
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
News Preview
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.08.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
News Preview
MediPharm announces it will release its second quarter 2025 financial results before markets open on Thursday, August 14th, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.07.2025
LABS
LISTED
TSX
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
News Preview
MediPharm Labs Launches New Shake & Puff CBN THC Nighttime Metered Dose Inhaler in Canada....
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
LABS
LISTED
TSX
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
News Preview
MediPharm Announces Election of All Seven Company Director Nominees at 2025 Annual and Special Meeting of Shareholders....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.06.2025
LABS
LISTED
TSX
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
News Preview
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to respond to a misleading press release published earlier today by Apollo Technology Capital Corporation (“Apollo”) prematurely claiming...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
13.06.2025
LABS
LISTED
TSX
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
News Preview
Independent proxy advisor Glass Lewis recommends that MediPharm shareholders vote for all of the Company's director nominees....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
LABS
LISTED
TSX
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
News Preview
MediPharm reminds shareholders to vote for proven strategy and team in advance of deadline, July 13, 2025 at 3:00pm EDT....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
LABS
LISTED
TSX
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
News Preview
Ontario Superior Court of Justice fully dismisses application by dissident shareholder Apollo against MediPharm Labs....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2025
LABS
LISTED
TSX
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
News Preview
MediPharm closes sale of Hope, BC facility and expands international cultivation capacity at EU GMP-certified facility in Napanee, ON....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2025
LABS
LISTED
TSX
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
News Preview
MediPharm Labs responds to allegations from dissident shareholder Apollo, intentionally or recklessly fabricated as part of its campaign of misinformation....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
LABS
LISTED
TSX
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
News Preview
TORONTO, May 26, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has begun production on novel cannabis metered dose inhalers for the EU and the United Kingdom, made...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.05.2025
LABS
LISTED
TSX
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
News Preview
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (“MediPharm”, the “Company”, or “we”), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with information related to three of the six directors (the “Dissident Nominees”) nominated by Apollo Technology Capital Corporation...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.05.2025
LABS
LISTED
TSX
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
News Preview
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its previously-announced agreement (the “Purchase Agreement”) for the sale of MediPharm’s facili...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.05.2025
LABS
LISTED
TSX
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
News Preview
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its shareholders to publicly available information about Regan McGee, the controlling shareholder, director, Chairman and CEO of Apollo Technology Capital Co...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
LABS
LISTED
TSX
COMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures, Excessive Executive Compensation, and Troubling Lack of T
News Preview
Launches Campaign Website at www.CureMediPharm.com, Which Articulates 5-Pillar Plan to Rebuild Company
Details How MediPharm Labs is Hemorrhaging Money at an Alarming Rate and is on Pace to Run Out of Cash by November 2025
Exorbitant Executive Compensation Packages Despite Persistent Losses Demonstrate a Board and Management Team Misaligned with...
Themefolio
Profiler
Peergroup
© PR Newswire
20.05.2025
LABS
LISTED
TSX
COMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures, Excessive Executive Compensation, and Troubling Lack of T
News Preview
Launches Campaign Website at www.CureMediPharm.com, Which Articulates 5-Pillar Plan to Rebuild Company
Details How MediPharm Labs is Hemorrhaging Money at an Alarming Rate and is on Pace to Run Out of Cash by November 2025
Exorbitant Executive Compensation Packages Despite Persistent Losses Demonstrate a Board and Management Team Misaligned with...
Themefolio
Profiler
Peergroup
© PR Newswire
16.05.2025
LABS
LISTED
TSX
Apollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
News Preview
MediPharm is Dangerously Low On Cash and is On Track to Run Out of Money by November Unless Wholesale Change Occurs
MediPharm Lost Over $3.3 Million in Q1 2025 While Management Offered No Clear Plan to Achieve Profitability or Commitment to Reduce Waste or Excessive Spending
Apollo Capital Warns Shareholders Not to Be Misled by Management's Rosy...
Themefolio
Profiler
Peergroup
© PR Newswire
16.05.2025
LABS
LISTED
TSX
Apollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
News Preview
MediPharm is Dangerously Low On Cash and is On Track to Run Out of Money by November Unless Wholesale Change Occurs
MediPharm Lost Over $3.3 Million in Q1 2025 While Management Offered No Clear Plan to Achieve Profitability or Commitment to Reduce Waste or Excessive Spending
Apollo Capital Warns Shareholders Not to Be Misled by Management's Rosy...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
LABS
LISTED
TSX
MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees
News Preview
TORONTO, May 15, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with additional information about the six nominees for its board of directors (the "Dissident Nominees") submitted by Apollo Technology Capital Corpora...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2025
LABS
LISTED
TSX
MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees
News Preview
TORONTO, May 15, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with additional information about the six nominees for its board of directors (the "Dissident Nominees") submitted by Apollo Technology Capital...
Themefolio
Profiler
Peergroup
© PR Newswire
14.05.2025
LABS
LISTED
TSX
MediPharm Labs Announces Strong Q1 2025 Results
News Preview
Achieves Positive Adjusted EBITDA(1)Revenue of $10.8 Million, an Increase of 11% over Q1 202487% Growth in International Medical Cannabis Revenue, Forming 55% of Total RevenueGross Profit of $4.2 million, or 39% of Total Revenue, Improved Significantly over Q1 2024Management to Host Conference Call / Webcast on May 14, 2025 at 10:00 am ETTORONTO,...
Themefolio
Profiler
Peergroup
© PR Newswire
14.05.2025
LABS
LISTED
TSX
MediPharm Labs Announces Strong Q1 2025 Results
News Preview
Achieves Positive Adjusted EBITDA(1)Revenue of $10.8 Million, an Increase of 11% over Q1 202487% Growth in International Medical Cannabis Revenue, Forming 55% of Total RevenueGross Profit of $4.2 million, or 39% of Total Revenue, Improved Significantly over Q1 2024Management to Host Conference Call / Webcast on May 14, 2025 at 10:00 am ETTORONTO,...
Themefolio
Profiler
Peergroup
© PR Newswire
13.05.2025
LABS
LISTED
TSX
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
News Preview
TORONTO, May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Special Meeting of Shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
13.05.2025
LABS
LISTED
TSX
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
News Preview
TORONTO, May 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Special Meeting of Shareholders, sche...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
News Preview
TORONTO, May 9, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2025, before markets open on Wednes...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
News Preview
TORONTO, May 9, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2025, before markets open on...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
LABS
LISTED
TSX
MediPharm Labs Responds to Dissident Shareholder's Filing
News Preview
TORONTO, May 8, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is aware of the dissident proxy circular filed on May 7, 2025 (the "Dissident Circular") by Apollo Technology Capital Corporation ("Apollo")....
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2025
LABS
LISTED
TSX
MediPharm Labs Responds to Dissident Shareholder's Filing
News Preview
TORONTO, May 8, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is aware of the dissident proxy circular filed on May 7, 2025 (the "Dissident Circular") by Apollo Technology Capital Corporation ("Apollo")....
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
LABS
LISTED
TSX
MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results
News Preview
Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4.
TORONTO, March 31, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-b...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results
News Preview
TORONTO, March 26, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its full year and fourth quarter financial results for the three and twelve months ended Dec...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results
News Preview
TORONTO, March 26, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its full year and fourth quarter financial results for the three and twelve months ended December 3...
Themefolio
Profiler
Peergroup
© PR Newswire
10.02.2025
LABS
LISTED
TSX
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health
News Preview
TORONTO, Feb. 10, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to Kensana Health Inc. ("Kensana Health"), which was to be completed through the sale of the Company's whol...
Themefolio
Profiler
Peergroup
© PR Newswire
10.02.2025
LABS
LISTED
TSX
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health
News Preview
TORONTO, Feb. 10, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to Kensana Health Inc. ("Kensana Health"), which was to be completed through the sale of the Company's wholly-owne...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2025
LABS
LISTED
TSX
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
News Preview
TORONTO, Jan. 16, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to be completed pursuant to the terms of a share purchase agreement (the "Purchas...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2025
LABS
LISTED
TSX
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
News Preview
TORONTO, Jan. 16, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to be completed pursuant to the terms of a share purchase agreement (the "...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
LABS
LISTED
TSX
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
News Preview
MediPharm Labs expands its Brazilian presence where the medical cannabis market is estimated to be worth $198 million in 2024, serving over 670,000 patients.1Products include full-spectrum, GMP sublingual oral solutions with extensive pharmaceutical validation and characterization.Teuto is one of Brazil's largest pharmaceutical manufacturers of b...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
LABS
LISTED
TSX
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
News Preview
MediPharm Labs expands its Brazilian presence where the medical cannabis market is estimated to be worth $198 million in 2024, serving over 670,000 patients.1Products include full-spectrum, GMP sublingual oral solutions with extensive pharmaceutical validation and characterization.Teuto is one of Brazil's largest pharmaceutical manufacturers of b...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
LABS
LISTED
TSX
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
News Preview
TORONTO, Dec. 17, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased to announce that they have entered into a share purchase agreement (the "Purchase Agreement") for the purchase and sale of MediPharm's facility in Napanee, On...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
LABS
LISTED
TSX
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
News Preview
TORONTO, Dec. 17, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased to announce that they have entered into a share purchase agreement (the "Purchase Agreement") for the purchase and sale of MediPharm's facility in Napanee, Ontario (...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
LABS
LISTED
TSX
MediPharm Labs Reports Third Quarter Results
News Preview
Strong Growth in International GMP Medical Markets
TORONTO, Nov. 14, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
LABS
LISTED
TSX
MediPharm Labs Reports Third Quarter Results
News Preview
Strong Growth in International GMP Medical Markets
TORONTO, Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30,...
Themefolio
Profiler
Peergroup
© PR Newswire
11.11.2024
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
News Preview
TORONTO, Nov. 11, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its third quarter financial results for the three and nine months ended September 30, 2024, before m...
Themefolio
Profiler
Peergroup
© PR Newswire
11.11.2024
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
News Preview
TORONTO, Nov. 11, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its third quarter financial results for the three and nine months ended September 30, 2024, b...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2024
LABS
LISTED
TSX
MediPharm Labs Announces $2.1M Debt Repayment
News Preview
Company Now Materially Debt Free with Over $13M in Cash
TORONTO, Sept. 17, 2024 /CNW/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is pleased to announce that it has paid off the entire remaining convertible debt amount of $2.1 m...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2024
LABS
LISTED
TSX
MediPharm Labs Announces $2.1M Debt Repayment
News Preview
Company Now Materially Debt Free with Over $13M in Cash
TORONTO, Sept. 17, 2024 /PRNewswire/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is pleased to announce that it has paid off the entire remaining convertible debt amount of...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
LABS
LISTED
TSX
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
News Preview
TORONTO, Aug. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and six months ended June 30, 2024 ("Q2 2024")....
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2024
LABS
LISTED
TSX
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
News Preview
TORONTO, Aug. 14, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and six months ended June 30, 2024 ("Q2 2024")....
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
LABS
LISTED
TSX
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
News Preview
TORONTO, Aug. 8, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended June 30, 2024, before markets open on Wedne...
Themefolio
Profiler
Peergroup
© PR Newswire
13.08.2024
LABS
LISTED
TSX
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
News Preview
TORONTO, Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended June 30, 2024, before markets open o...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
News Preview
TORONTO, Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended June 30, 2024, before markets open o...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
News Preview
TORONTO, Aug. 8, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended June 30, 2024, before markets open on Wedne...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
